Elevance Health, Inc. $ELV Stock Holdings Boosted by Focus Advisor Solutions LLC

Focus Advisor Solutions LLC lifted its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 606.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,715 shares of the company’s stock after purchasing an additional 8,340 shares during the period. Focus Advisor Solutions LLC’s holdings in Elevance Health were worth $3,778,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of ELV. Activest Wealth Management increased its stake in Elevance Health by 146.2% in the 3rd quarter. Activest Wealth Management now owns 64 shares of the company’s stock worth $25,000 after purchasing an additional 38 shares in the last quarter. Kilter Group LLC acquired a new stake in Elevance Health during the 2nd quarter worth about $28,000. Elevation Wealth Partners LLC lifted its stake in Elevance Health by 600.0% during the second quarter. Elevation Wealth Partners LLC now owns 105 shares of the company’s stock valued at $41,000 after buying an additional 90 shares in the last quarter. Tacita Capital Inc purchased a new stake in Elevance Health during the second quarter valued at about $44,000. Finally, Danske Bank A S purchased a new stake in Elevance Health during the second quarter valued at about $44,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Ratnakar Lavu sold 1,300 shares of Elevance Health stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $440.00, for a total transaction of $572,000.00. Following the completion of the sale, the executive vice president directly owned 14,849 shares in the company, valued at $6,533,560. The trade was a 8.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ramiro Peru purchased 1,000 shares of the stock in a transaction that occurred on Thursday, November 19th. The stock was purchased at an average cost of $383.86 per share, with a total value of $383,860.00. Following the purchase, the director owned 11,908 shares in the company, valued at $4,571,004.88. This represents a 9.17% increase in their position. The SEC filing for this purchase provides additional information. 0.34% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on ELV shares. Mizuho set a $490.00 target price on shares of Elevance Health in a research report on Friday, October 23rd. Argus upgraded shares of Elevance Health from a “hold” rating to a “buy” rating and set a $510.00 price target on the stock in a report on Wednesday. Royal Bank Of Canada upped their price target on shares of Elevance Health from $424.00 to $455.00 and gave the company a “sector perform” rating in a research report on Thursday, October 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Elevance Health in a research note on Wednesday, November 11th. Finally, Wall Street Zen upgraded shares of Elevance Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Sixteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $458.91.

Get Our Latest Analysis on Elevance Health

Elevance Health Stock Up 1.1%

NYSE:ELV opened at $394.40 on Friday. The business’s fifty day moving average price is $415.92 and its 200 day moving average price is $376.97. The firm has a market capitalization of $85.21 billion, a price-to-earnings ratio of 16.82, a PEG ratio of 2.13 and a beta of 0.63. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.68. Elevance Health, Inc. has a 1-year low of $274.84 and a 1-year high of $450.69.

Elevance Health (NYSE:ELV – Get Free Report) last released its earnings results on Wednesday, October 21st. The company reported $6.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.71 by $2.28. The company had revenue of $50.44 billion during the quarter, compared to the consensus estimate of $49.28 billion. Elevance Health had a net margin of 2.55% and a return on equity of 14.97%. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.03 EPS. On average, sell-side analysts forecast that Elevance Health, Inc. will post 29.16 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 18th. Stockholders of record on Friday, December 4th will be paid a dividend of $1.72 per share. The ex-dividend date of this dividend is Friday, December 4th. This represents a $6.88 dividend on an annualized basis and a dividend yield of 1.7%. Elevance Health’s dividend payout ratio (DPR) is 29.34%.

Elevance Health Company Profile

(Free Report)

Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.

Read More

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).

Institutional Ownership by Quarter for Elevance Health (NYSE:ELV)

Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.